Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 303

Joint MOTION for Leave to File Excess Pages of Markman Briefs by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole)

Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Doc. 303

Case 1:05-cv-12237-WGY

Document 303

Filed 03/01/2007

Page 1 of 3

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS ____________________________________ AMGEN INC., ) ) Plaintiff, ) ) v. ) CIVIL ACTION No.: 05-cv-12237WGY ) ) F. HOFFMANN-LA ROCHE LTD, ) ROCHE DIAGNOSTICS GmbH, and ) HOFFMANN-LA ROCHE INC. ) ) Defendants. ) ) ____________________________________) JOINT MOTION FOR LEAVE TO FILE OVERSIZE MARKMAN BRIEFS The parties Amgen Inc. ("Amgen") and F. Hoffmann-La Roche Ltd, Roche Diagnostics GmbH, and Hoffmann-La Roche Inc. ("Roche") (collectively "the parties") hereby jointly request leave to file their respective claim construction briefs in excess of the twenty-page limitation established by Local Rule 7.1(b)(4). Specifically, the parties request that the page limit of the principal claim construction briefs and for the responsive claim construction briefs be extended to thirty-five (35) pages. As grounds for this motion, the parties state as follows: 1. Claim construction in this case presents complex factual and legal issues

concerning six United States patents that require a thorough and detailed exposition in order to fully and adequately address the meaning of the many claim terms from each asserted patent. 2. Although the parties will endeavor to present a concise argument in both the

principal briefs and the responsive briefs, the complex, technical nature of the six patents at issue

Dockets.Justia.com

Case 1:05-cv-12237-WGY

Document 303

Filed 03/01/2007

Page 2 of 3

necessitates a detailed discussion, which will likely exceed the twenty-page limit of L.R. 7.1(b)(4). CERTIFICATE PURSUANT TO LOCAL RULE 7.1 I certify that counsel for the parties have conferred in an attempt to resolve or narrow the issues presented by this motion and that counsel for Amgen has assented to this motion. /s/ Nicole A. Rizzo Nicole A. Rizzo Date: March 1, 2007 AMGEN INC. By its attorneys, /s/ Linda A. Baxley Michael R. Gottfried (BBO# 542156) D. Dennis Allegretti (BBO# 545511) Patricia R. Rich (BBO# 640578) DUANE MORRIS LLP 470 Atlantic Avenue, Ste 500 Boston, MA 02210 Tel. [phone] F. HOFFMANN-LA ROCHE LTD, ROCHE DIAGNOSTICS GMBH, and HOFFMANN-LA ROCHE INC. By their attorneys, /s/ Nicole A. Rizzo Lee Carl Bromberg (BBO# 058480) Julia Huston (BBO# 562160) Keith E. Toms (BBO# 663369) Nicole A. Rizzo (BBO # 663853) BROMBERG & SUNSTEIN LLP 125 Summer Street Boston, MA 02110 Tel. [phone] [e-mail] Leora Ben-Ami (pro hac vice) Mark S. Popofsky (pro hac vice) Patricia A. Carson (pro hac vice) Thomas F. Fleming (pro hac vice) Howard Suh (pro hac vice) Peter Fratangelo (BBO# 639775) KAYE SCHOLER LLP New York, NY 10022 [phone]

Deborah Fishman Lloyd R. Day, Jr. David M. Madrid Linda A. Baxley DAY CASEBEER MADRID & BATCHELDER LLP 20300 Stevens Creek Boulevard, Ste 400 425 Park Avenue Cupertino, CA 95014 Tel. [phone] [e-mail]

2

Case 1:05-cv-12237-WGY

Document 303

Filed 03/01/2007

Page 3 of 3

William Gaede III MCDERMOTT WILL & EMERY 3150 Porter Drive Palo Alto, CA 94304 Tel. [phone] Michael F. Borun Kevin M. Flowers MARSHALL, GERSTEIN & BORUN LLP 233 South Wacker Drive 6300 Sears Tower Chicago IL 60606 Tel. [phone] Stuart L. Watt Wendy A. Whiteford Monique L. Cordray Darrell G. Dotson Kim Morley AMGEN INC. One Amgen Center Dr. Thousand Oaks, CA 91320-1789 [phone] CERTIFICATE OF SERVICE I hereby certify that this document filed through the ECF system will be sent electronically to the registered participants as identified on the Notice of Electronic Filing (NEF) and paper copies will be sent to those indicated as non registered participants on March 2, 2007. /s/ Nicole A. Rizzo Nicole A. Rizzo
03099/00501 625635.1

3